HBOT Conversations:
Robert Beckman & NBIRR Study
Robert Beckman, Ph.D., Founder of the TreatNow Coalition in Arlington, Virginia, discusses the National Brain Injury Rescue Rehabilitation study focused on the use of Hyperbaric Oxygen Therapy for brain injuries. Beckman has a passion for data and helping veterans, which is what ultimately got him first involved in Hyperbaric Oxygen Therapy back in 2008. He was one of many, participating with an elite group of doctors and HBOT experts, who organized and oversaw the results of NBIRR, a multi-center HBOT trial for mild traumatic brain injury with post-concussive symptoms.
The TreatNow Coalition’s Mission is to Stop service member suicides by identifying and treating veterans and others suffering from brain wounds, TBI, PTSD, and Concussion.
Watch the Podcast
HBOT News podcast host, Edward di Girolamo, talks with guest, Robert Beckman, founder of Treatnow.org, who was instrumental in the compilation and release of The National Brain Injury Rescue and Rehabilitation Study – a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms.
It took over a decade for that study to be completed and published. Once it was, it not only opened a door for veterans and others who were looking for a way to heal from head trauma, the NBIRR study ignited other studies to start, focusing solely on the safety & efficacy of Hyperbaric Oxygen Therapy for brain injuries.
Beckman discusses some of the challenges he has witnessed over the years, including the Army declaring that HBOT does not work. After combing through the data, Beckman states that their analysis is rooted in a “lie” about the sham they used in their study; everyone got better. This starts an in-depth conversation between di Girolamo and Beckman about the frustration of the government so easily dismissing HBOT, inflammation linked to PTSD, the stigma of PTSD being a personal and not a physical problem, the disappointment that most veterans don’t even know HBOT exists, and why more is not being done to heal our veterans from these invisible injuries of war.
Beckman proudly states that what started as nine clinics to treat veterans under the NBIRR study, has grown to about 135 clinics across the country that specialize in treating veterans with HBOT for free or reduced rates. Additionally, there are now a combined 12,500-plus success stories from these 135 clinics of individuals with TBI, PTSD, and mTBI who have completed 40 treatments/dives.
Beckman gives surgical statistics relating to HBOT and explains that by pre-oxygenating and post-oxygenating via hyperbaric chambers, patients can benefit from a 30-40% faster healing rate. He points out that countless professional athletes are now using hyperbaric oxygen therapy for faster recuperation to treat pain, injuries, and inflammation; and hyperbarics is being used all over the world right now for successfully treating COVID long-haulers. He states that COVID long-haulers are hypoxic suffering patients, and data exists that military personnel who have experienced the blow of an IUD are suffering in much of the same manner – it’s that lack of oxygen to the brain and all parts of the suffering body that HBOT helps.
di Girolamo asks the question so many of us are curious about, “If HBOT obviously works, why isn’t the military admitting to this? Why aren’t we using it more?” Beckman suggests we read this particular blog on his website that sheds much light on the subject, The Obvious Question: If HBOT works, why aren’t we using it?
Beckman reminds di Girolamo – and all of us – that this is a marathon. Yes, they’ve made great strides over the past two decades in education and research for hyperbaric oxygen therapy, but they still have a way to go. He continues to be optimistic that one day we’ll all witness our shared goal of eliminating the suicide epidemic by utilizing HBOT to thoroughly heal brain injuries.
Guest
Robert L. Beckman, Ph.D.
Dr. Beckman has been building knowledge management systems most of his professional career, primarily in the Intelligence Community and DOD. He is currently helping to run the Clinical Trial researching TBI and PTSD in brain-injured wounded warriors. He is responsible for sustaining the national network of hyperbaric clinics as well as improving the technology platform for data collection and analysis. He is a former USAF KC-135 pilot and a Vietnam Veteran.
TreatNow.org
(571) 549-4258
beckmanr88@gmail.com
Contact TreatNow.org
https://treatnow.org/
Subscribe Now, It’s Free !
Recent HBOT News
Growth Hormone Deficiency: Health and Longevity
Abstract The important role of GH in the control of mammalian longevity was first deduced from extended longevity of mice with genetic GH deficiency (GHD) or GH resistance. Mice with isolated GHD (IGHD) due to GHRH or GHRH receptor mutations, combined deficiency of...
Why is Justin Bieber Sleeping in a hyperbaric Oxygen Chamber?
Find out why pop star Justin Beiber has decided to sleep in a hyperbaric oxygen chamber. "Justin Bieber is testing out some futuristic healing technology. The pop star, 25, showed fans his new nighttime routine on his Instagram Stories on Sunday, passing his phone off...
Clinical Trial – The Role of Hyperbaric Oxygen and Neuropsychological Therapy in Cognitive Function Following Traumatic Brain Injury
Traumatic brain injury (TBI) caused by accidents is a very important public health problem in
Taiwan. There are many people with brain damage and cognitive dysfunction caused by traumatic
brain injury every year. Currently, there is no effective treatment for cognitive dysfunction
caused by traumatic brain injury. Evidence from clinical studies in recent years suggests
that hyperbaric oxygen therapy may be a treatment for repairing nerves after brain injury.
Many studies have shown that oxidative stress and inflammatory responses play an important
role in the pathogenesis of the central nervous system. In recent years, our research team
has shown that oxidative stress and inflammatory response are significantly associated with
the prognosis of patients with traumatic brain injury, cerebral hemorrhage, and stroke
patients. More and more evidences also show that oxidative stress and inflammatory response
play an important role in the neuropathological changes of mental cognitive sequelae after
traumatic brain injury. This injury may be gradual from the time of head trauma. This process
begins with the generation of oxidative stress and free radicals. When the cell repair and
free radical scavenging system can not effectively overcome the excessive production of free
radicals, an oxidative damage reaction will occur, causing a series of inflammatory cells and
cytokines to be activated. Studies have also shown that when inhibiting those free radicals
that produce oxidative stress, the neurological function and cognitive function of the head
after trauma can be significantly improved.
It is becoming widely acknowledged that the combined action of hyperoxia and hyperbaric
pressure leads to significant improvement in tissue oxygenation while targeting both
oxygenand pressure-sensitive genes, resulting in improved mitochondrial metabolism with
anti-apoptotic and anti-inflammatory effects. The investigators published an article this
year showing that hyperbaric oxygen therapy can improve the prognosis of patients with acute
stroke and increase endothelial progenitor cells in the systemic circulation.
The investigators plan to conduct this research project through hyperbaric oxygen therapy and
neuropsychological therapy, and using scientific tests and neurocognitive function
assessments. The investigators hope to answer the following questions: (1) Whether the
treatment of hyperbaric oxygen can improve oxidative stress and inflammatory response after
brain injury, and observe changes in biomarker concentration; (2) Whether hyperbaric oxygen
therapy and neuropsychological therapy can improve cognitive function after brain injury; and
(3) which biomarkers are factors that influence cognitive function prognosis.